Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma
- 17 January 2002
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 21 (3), 479-482
- https://doi.org/10.1038/sj.onc.1205133
Abstract
Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2A-related pheochromocytoma. Two of nine tumors investigated, however, did not reveal either of these mechanisms. In the present study, we therefore searched for other possible mechanisms underlying the pathogenesis of MEN 2A-related pheochromocytoma. Hereditary pheochromocytoma also occurs in patients with von Hippel-Lindau (VHL) disease, a syndrome consisting of tumors caused by inactivation of the VHL tumor suppressor gene. A subset of sporadic pheochromocytomas have somatic mutations in RET or VHL, suggesting that both genes contribute to pheochromocytoma pathogenesis in a subset of tumors. It is unknown, however, whether VHL gene alterations would be associated with tumorigenesis in hereditary, MEN 2-related pheochromocytoma. We therefore investigated four pheochromocytomas from patients with MEN 2A and RET germline mutations for the presence of allelic deletion and/or somatic mutation of the VHL gene. LOH analysis using the polymorphic markers D3S1038 and D3S1110 that map to the VHL gene locus 3p25/26, revealed evidence for somatic VHL gene deletion in all four MEN 2A-related pheochromocytomas. Mutation analysis of the VHL gene showed frameshift mutations in two tumors and a splice acceptor mutation in one tumor. The remaining tumor did show LOH but not mutation of the VHL gene. These results suggest that somatic genetic alterations of the VHL gene may play a role in the tumorigenesis of some MEN 2A-related pheochromocytomas.Keywords
This publication has 25 references indexed in Scilit:
- Differential Genetic Alterations in von Hippel-Lindau Syndrome-Associated and Sporadic Pheochromocytomas 1Journal of Clinical Endocrinology & Metabolism, 2000
- Losses of Chromosomes 1p and 3q Are Early Genetic Events in the Development of Sporadic PheochromocytomasThe American Journal of Pathology, 2000
- Sporadic Pheochromocytomas Are Rarely Associated with Germline Mutations in the vhl Tumor Suppressor Gene or the ret Protooncogene 1Journal of Clinical Endocrinology & Metabolism, 1997
- Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.Journal of Medical Genetics, 1995
- Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.Journal of Medical Genetics, 1995
- The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.Journal of Clinical Endocrinology & Metabolism, 1995
- von Hippel-Lindau disease: genetic, clinical, and imaging features.Radiology, 1995
- Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumoursHuman Genetics, 1994
- Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.JCI Insight, 1991